Radionuclide liver and bone scanning in the evaluation of patients with endometrial carcinoma

Journal Article · Tue Dec 01 04:00:00 EST 1981 · Radiology; (United States)

DOI:https://doi.org/10.1148/radiology.141.3.6272356· OSTI ID:5801308

Mettler, F A; Christies, J H; Garcia, J F; Baldwin, M H; Wicks, J D; Barton, S A

Staging bone scans or skeletal surveys were obtained of 97 patients with endometrial carcinoma. Of the 77 patients with Stage I or II disease, no metastases were identified at staging. Three patients in the entire series demonstrated bony metastases; all of these metastases were detectable by radionuclide bone scan and radiographic bone survey. Eighty-nine patients were examined with radionuclide liver/spleen scanning at the time of staging. Four of the 89 initial scans were interpreted as demonstrating hepatocellular disease, and all four patients had abnormal liver function studies. Only one patient demonstrated a possible hepatic metastasis at initial diagnosis. This patient also had abnormal liver function studies. Based on these results, bone surveys and radionuclide bone scans are not indicated as screening procedures in endometrial carcinoma. It is suggested that screening for liver metastases in patients with endometrial carcinoma is not warranted in patients with normal liver function studies.

• Research Organization: Univ. of New Mexico Hospital, Albuquerque
• OSTI ID: 5801308
• Journal Information: Radiology; (United States), Journal Name: Radiology; (United States) Vol. 141:3; ISSN RADLA
• Country of Publication: United States
• Language: English

Related Subjects

550601* -- Medicine-- Unsealed Radionuclides in Diagnostics
62 RADIOLOGY AND NUCLEAR MEDICINE
BODY
COUNTING TECHNIQUES
DIAGNOSIS
DIAGNOSTIC TECHNIQUES
DIGESTIVE SYSTEM
DISEASES
EVALUATION
GLANDS
LIVER
METASTASES
NEOPLASMS
ORGANS
PATIENTS
RADIOISOTOPE SCANNING
SCINTISCANNING
SKELETON
SPLEEN